* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Word file (122 KB )
Gene therapy wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Oncogenomics wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Genetic engineering wikipedia , lookup
Primary transcript wikipedia , lookup
DNA supercoil wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
SNP genotyping wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Epigenomics wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
Molecular cloning wikipedia , lookup
Designer baby wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Deoxyribozyme wikipedia , lookup
DNA vaccination wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Point mutation wikipedia , lookup
Microsatellite wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Helitron (biology) wikipedia , lookup
Microevolution wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genomic library wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Supplementary Methods Yeast transformation and plasmid shuffle All of the 24 pol30 mutants were in Plasmids pBL-230-x (ARS, CEN TRP1 pol30x). Sixteen mutants were kindly provided by Peter Burgers 1,2. We made six additional mutants based on information that the corresponding human PCNA mutants bound weakly to the human p150 (CAC1) in vitro compared to wild type (K. Shibahara, Z. Zhang, Morioka, H, T. Tsurimoto, and B. Stillman, unpublished) by procedures described in the Instruction Manual for the QuikChangeTM Site-Directed Mutagenesis Kit (Stratagen). Two mutants, pol30-203 and pol30-204 , were made based on information that the corresponding Drosophila PCNA mutations suppressed position effect varigation. Each of the PCNA mutants was introduced into yeast cells by plasmid shuffle. To select for loss of the plasmid pBL-211 in yeast strains with the URA3 gene integrated at the chromosome VIIL, individual colonies were tested by colony PCR using primers pcna(sc)-3 and pcna(sc)-4 that recognized POL30 at its endogenous locus and on the plasmid pBL-211, but not on the plasmid pBL230. To select for loss of the plasmid pBL211 in yeast strains without the URA3 gene on the chromosome VIIL, we replica-plated yeast cells onto FOA plates, and FOA resistant colonies were picked. C-terminal tagging of Cac1p and Cac2p Cac1p and Cac2p were tagged at their C-termini with three HA epitopes and thirteen Myc epitopes, respectively, using PCR modules described by Longtine et al. 3. The PCR modules used were pFA6a-3HA-kanMX6 and pFA6a-13Myc-kanMX6, respectively. The sequences of the all of the primers used in this study are listed in Supplementary Table 3. The PCR modules were amplified by the Cloned pfu DNA Polymerase (Stratagene). PCR products were purified, and used to transform the parental yeast strain (W303-1, MATa) according to procedures as described 3. Clones in which 1 Cac1p or Cac2p were tagged at their C-termini were identified by colony PCR using one primer (kan(r)-1) that annealed within the kan gene and another within the CAC1 gene (cac1-f) or CAC2 gene (cac2-f) (Supplementary Table 3). The clones that gave rise to PCR products with the expected size were further analyzed by Western Blotting using monoclonal antibodies against the HA epitope (12CA5) or the Myc epitopye (9E10). During subsequent crosses, the selection marker kanMX6 segregated 2:2, indicating that only the kanMX6 gene was integrated into one locus in the genome. These two tags did not affect their association with each other since monoclonal antibodies that recognized the HA epitope specifically immunoprecipitated Cac2p-13Myc (data not shown). Furthermore, these two tags did not affect the function of CAF-1 in silencing (data not shown). Production of antiserum against S. cerevisiae PCNA The S. cerevisiae PCNA was expressed in E. coli and purified to homogeneity according to procedures as described 4. The full-length protein was injected into rabbits, and sera were tested. Antisera from the rabbit 871 recognized purified PCNA and reacted with one protein from yeast whole cell extracts whose molecular weight matched that of purified PCNA. Cloning, expression and purification of GST-Cac1p To clone pol30 mutants for in vitro transcription/translation, the entire coding sequence of each of the mutants was amplified by PCR using primers pcna(sc)-6 and pcna(sc)-7, and ligated into vector pT7Blue-2 (Novagen) to generate plasmids pZG10-13 as listed in Supplementary Table 4. Selected clones were sequenced to confirm no other errors were introduced by PCR. Each of the PCNA mutants in pT7Blue-2 was subcloned into the vector pET3c to generate plasmids pZG14-17. To clone GST-Cac1p, the entire open reading frame of CAC1 was amplified by PCR using primers cac1(Eco RI) and 2 cac1(Xho I). The resulting PCR products were digested with EcoRI and Xho I and ligated into vector pGEX-5X1 to generate plasmid pZG18. The coding region of CAC1 from selected clones was sequenced to verify that no errors were introduced by PCR amplification. All of the plasmids generated from this study were listed in the Supplementary Table 4. To express GST-Cac1p in BL-21(DE3), bacterial cells were grown in LB media containing 50 g/ml Ampicillin at 24 ºC to OD600 of 0.5. They were then induced with 0.4 mM IPTG for five hours. After induction cells were harvested and frozen at –70 ºC. Bacterial cells from 1 liter of LB culture were resuspended in 25 ml buffer A (25 mM Tris, pH7.2, 10% glycerol, 0.05% NP40, 100 mM NaCl, 2 mM DTT) plus protease inhibitors (1 mM PMSF, 10 g/ml leupeptin, 1 g/ml pepstatin A, 2 mM benzamidine, 10 g /ml aprotinin and 2 mM pefabloc), lysed by two passages through a French Press and sonication. The resulting lysate was cleared by centrifugation, and loaded onto a 50 ml-Hydroxyapatite (Bio-Gel http Gel) column equilibrated with buffer A with 1 mM PMSF. The column was washed with 100 ml of buffer A first, then 100 ml of buffer B (300 mM Phosphate, pH 7.2, 10% glycerol, 0.05% NP-40). After washing, GST-Cac1p was eluted with 100 ml of buffer C (600 mM Phosphate, pH 7.2, 10% glycerol, 0.05% NP-40), incubated with 0.8 ml of Glutathione sepharose beads for at least 6 hours at 4 ºC. The beads were then washed four times with 25 ml TBS each. Since GST-Cac1p was very prone to proteolysis, we used the beads immediately for in vitro binding assay described below. GST-REG was induced at 37 ºC for 2 hours, and purified by glutathione sepharose beads. Protease inhibitors (1 mM PMSF, 2 mM pefabloc) were added to buffer B, buffer C and TBS before use. Southern Blot analysis of telomere length 3 Yeast DNA was isolated from vegetative cultures by a standard method 5. Two g of DNA from each sample were digested with XhoI for 6 hours. The resulting fragments were resolved on a 0.8% agarose gel, transferred overnight to a nitrocellulose membrane, and hybridized with oligonucleotide (TG)20 labeled with 32P by T4 polynucleotide kinase. Determination of sensitivity towards DNA damage agents Yeast cells were grown to early logarithmic phase, and ten-fold serial dilutions were made starting OD600 of 0.6. To determine sensitivity to UV induced DNA damage, 5 l of each dilution were plated onto YPD plates. The plates were irradiated with UV at a dosage of 0, 25, 50 and 100 J/m2, respectively, and incubated immediately in dark at 30 ºC for three days. To test bleomycin sensitivity, 5 l of each dilution were plated onto plates containing 0, 1 mU/ml, 3 mU/ml or 10 mU/ml bleomycin (Sigma). Cells were grown at 30 ºC for three days before photography. Supplementary references 1. Ayyagari, R., Impellizzeri, K. J., Yoder, B. L., Gary, S. L. & Burgers, P. M. A mutational analysis of the yeast proliferating cell nuclear antigen indicates distinct roles in DNA replication and DNA repair. Mol Cell Biol 15, 4420-4429 (1995). 2. Eissenberg, J. C., Ayyagari, R., Gomes, X. V. & Burgers, P. M. Mutations in yeast proliferating cell nuclear antigen define distinct sites for interaction with DNA polymerase delta and DNA polymerase epsilon. Mol Cell Biol 17, 6367-6378 (1997). 3. Longtine, M. S. et al. Additional modules for versatile and economical PCRbased gene deletion and modification in Saccharomyces cerevisiae. Yeast 14, 953-961 (1998). 4. Fien, K. & Stillman, B. Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex. Mol Cell Biol 12, 155-163 (1992). 5. Hoffman, C. S. & Winston, F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57, 267-272 (1987). 4 6. Kaufman, P. D., Kobayashi, R. & Stillman, B. Ultraviolet radiation sensitivity and reduction of telomeric silencing in Saccharomyces cerevisiae cells lacking chromatin assembly factor-I. Genes Dev 11, 345-357 (1997). 7. Game, J. C. & Kaufman, P. D. Role of Saccharomyces cerevisiae chromatin assembly factor-I in repair of ultraviolet radiation damage in vivo. Genetics 151, 485-497 (1999). 5 Figure legend for the Supplementary Figures Supplementary Figure 1. Conversion of “pink” colonies of the pol30-8 mutant to sectoring colonies. Three pink and two sectoring colonies were picked from YPD plates and assayed for the expression of the ADE2 gene at the HMR locus with time (X-axis) and percentage of “pink” colonies in the whole population (Y-axis) was determined. Note that sectored colonies remained predominantly pink after conversion. Supplementary Figure 2. Sensitivity towards DNA damage agents in pol30 and pol30 cac1∆ mutants. A. Sensitivity towards UV irradiation. Ten-fold serial dilutions of yeast cells with relevant genotypes identified at the left were dot-spotted onto YPD plates, irradiated with UV at a dosage displayed at the top of the Supplementary Figure 2A. B, Sensitivity towards bleomycin. The same dilutions of yeast cells were dot-spotted onto YPD plates containing the durg of bleomycin at concentrations exhibited at the top of Supplementary Figure 2B. The photos were taken after growth in dark for three days at 30 ºC. Supplementary Figure 3. Telomere length in wild type PCNA or mutants strains. A. A schematic representation of yeast telomeres. About two-third of yeast telomeres have both sub-telomeric repeats, Y’ and X. The Y’ element contains an unique XhoI site that is about 1.3 kb from chromosome ends. B. Yeast genomic DNA from each of the strains was digested with XhoI, resolved on a 0.8% agarose gel, transferred to a nitrocellulose membrane, and hybridized with poly TG probe. Yeast strains used were WT, 1, 6, 8, 22, 41, 42, 45, 79 that corresponded to ZGY003-x (x=WT, 1, 6, 8, 22, 41, 42, 45, 79), respectively, and cac1∆ (PKY106). 6 Supplementary Table 1 PCNA mutants affect silencing at telomere and HMR Allele mutations WT 1 2 6 8 9 13 79 14 16 81 18 22 41 42 45 46 200 201 202 203 204 205 206 207 wild type EK3,5AA EK5,7AA DD41,42AA RD61,63 ED104,105AA DR109,110AA LI126,128AA KE127,129AA EK143,146AA DI156,158AA DE187,189AA DE256,257AA Allele1+8 Allele 6+8 Allele 8+22 Allele 9+22 D97A D122A D256∆ P140L I195E DD97,122AA DD97,256A∆ DD122,256A∆ FOA Phenotype hmr::ADE2 +++ +++ +++ ++ +++ +++ +/+++ +++ +++ +++ +++ + + +++ +++ +++ +++ +++ +++ +++ +++ +++ P P ND W Sector, 5-10% LP ND ND LP ND ND ND ND P Sector, 5-10% LP W Sector, 5-10% LP ND ND ND ND ND ND ND ND ND Each of the pol30 mutants with amino acid changes listed in the second column was tested for telomeric silencing as described in Methods and reported as cell’s ability to grow on FOA containing media. Cells with the wild type POL30 grew on FOA plates quite efficiently (+++), suggesting that the URA3 gene was repressed. (+++) indicates that pol30 mutants were indistinguishable in growth compared to the POL30 ; ++, mutants exhibited minor growth difference; +, mutants could grow on FOA plates only at the lowest dilution (about 5 x104 cells per spot); +/-, mutants barely grew on FOA plates; -, mutants did not grow on FOA plates even at the lowest dilution. The growth was scored after 3 days of incubation at 30 ºC. Selected pol30 mutants were also tested for HMR repression using a qualitative colony color assay: P, pink; LP, light pink, W, white; 7 Sector, LP/W sectored colony. ND, not determined. The pol30 mutants showing reduction in silencing were highlighted. 8 Supplementary Table 2 Yeast strains used Strain Number Reference PKY090 PKY106 PKY741 RS1295 ZGY001 ZGY002 ZGY003 ZGY003-x ZGY004 ZGY004-x ZGY005 ZGY005-x ZGY006 ZGY006-x ZGY007 ZGY007-x ZGY008 ZGY008-x ZGY009 ZGY101 ZGY110 Kaufman et al. 6 MATa URA3-VIIL same as above MATa URA3-VIIL cac1∆::Leu2 Game & Kaufman 7 MATa pol30∆::hisG-URA3-hisG+pBL230(POL30) Rolf Sternglanz MATa, hmr::ADE2 this study MATa pol30∆+pBL230(POL30) this study MATa pol30∆+ [pBL-211(POL30 URA3)] this study MAT pol30∆ URA3-VIIL [pBL-211(POL30 URA3)] this study ZGY003+[pBL230-x TRP1]-[pBL-211] this study ZGY002 CAC1-3HA CAC2-13MYC this study ZGY004 +[pBL230-x TRP1]-[pBL-211] this study ZGY002 hmr::ADE2 this study ZGY005 +[pBL230-x TRP1]-[pBL-211] this study ZGY002 CAC1-3HA this study ZGY006 +[pBL230-x TRP1]-[pBL-211] this study ZGY003 cac1∆::LEU2 this study ZGY007 +[pBL230-x TRP1]-[pBL-211] this study ZGY005 cac1∆::LEU2 this study ZGY008 +[pBL230-x TRP1]-[pBL-211] this study cac1∆::LEU2 hmr::ADE2 this study MATa cac2::CAC2 13myc -kanMX6 this study MATa cac1∆::LEU2 cac2::CAC2 13myc -kanMX6 Genotype All of the yeast strains were derivative of W303-1 (leu2-3,112 ura3-1 his3-11,15 trp1-1 ade2-1 can1-100). X= wild type PCNA or mutant alleles listed in Supplementary Table 1. 9 Supplementary Table 3 Sequences of PCR primers used in this Study Name pcna(sc)-3 pcna(sc)-4 pcna(sc)-6 pcna(sc)-7 cac1(EcoRI) cac1(XhoI) cac1(f) cac2(f) kan(r)-1 cac1(tag)-f cac1(tag)-r cac2(tag)-f cac2(tag)-r DNA sequence 5’ GTAGCTGACGGTGATATCGG 3’ 5’ GTTGGATGTGGAAACCCTGAATAC 3’ 5’ CATATGTTAGAAGCAAAATTTGAAGAAGC 3’ 5’ TTATTCTTCGTCATTAAATTTAGGAGC 3’ 5’ AAAAGAATTCATGGAGCAACATCTCAAATCAATTC 3’ 5’ AAAACTCGAGTTACAAAGACGGGGTTGGCATATTTGC 5’ CCCATTGATACCAACAATATGCC 3’ 5’ ACTGAACAGCGCTGGTGGCG 3’ 5’CGTATGGGTAAAAGATGTTAATTAAC 3’ 5’ CGCAAATGGGTAATCAAAGACGCACAAAACTGGGAGA ATCTTCGAGCCAATGCAAATATGCCAACCCCGTCTTTGC GGATCCCCGGGTTAATTAA 3’ 5’ TTATTCAAAGTCCAAAAGGCTTGACTGTCGATCGTAGT GTTGTCGCCTTTTTCATGTATACCAATAAATAATCAGGAA TTCGAGCTCGTTTAAAC 3’ 5’ ATCCCCTGCAATAGTAGCGATAGTAAAAAGAGGCGC ATACATCCTACGCCAGTCGATTTGCGGATCCCCGGGTTA ATTAA 3’ 5’ ATATCTTCGCTGGCAAACTAGATTAGGCATTCTTATGT ACCGCATTAAATATATTAAAAAGAATTCGAGCTCGTTTA AAC 3’ 10 Supplementary Table 4 Plasmids constructed in this study Name Gene or mutant allele Parental Plasmid pol30-200 pol30-201 pol30-202 pol30-203 pol30-204 pol30-205 pol30-206 pol30-207 pol30-0 pol30-6 pol30-8 pol30-42 pol30-79 pol30-6 pol30-8 pol30-42 pol30-79 CAC1 pBL-230 pBL-230 pBL-230 pBL-230 pBL-230 pBL-230 pBL-230 pBL-230 pT7 Blue-2 pT7 Blue-2 pT7 Blue-2 pT7 Blue-2 pT7 Blue-2 pET3c pET3c pET3c pET3c pGEX-5x-1 pZG1 pZG2 pZG3 pZG4 pZG5 pZG6 pZG7 pZG8 pZG9 pZG10 pZG11 pZG12 pZG13 pZG14 pZG15 pZG16 pZG-17 pZG-18 11